Rate My Professor Hossein Jadvar

Dr. Jadvar's research specializes in translational molecular imaging, with current emphasis on prostate cancer, theranostics, and radiopharmaceutical therapy. He has authored or co-authored 267 peer-reviewed journal articles (Google Scholar h-index 53), 4 books, 41 book chapters, and holds 9 U.S. and European patents. Key publications include 'The Final Frontier: Toward Transformative Insights into the Pathophysiologic Adaptations to Microgravity with Molecular Imaging' (Journal of Nuclear Medicine, 2026), 'Therapy strategies to defeat prostate cancer heterogeneity' (Seminars in Nuclear Medicine, 2026), and 'Clinical Trials in Cancer Theranostics with Potential Near-Term Impact on Clinical Practice' (British Journal of Radiology, 2025). His scholarly impact is evident in over 10,000 citations and more than 350 invited lectures worldwide. Dr. Jadvar has received prestigious awards such as the American College of Nuclear Medicine Lifetime Achievement Award (2023), Massachusetts General Hospital Distinguished Alumnus Award (2024), USC Department of Radiology Outstanding Teacher of the Year (2023-2024), and Academy for Radiology and Biomedical Imaging Research Distinguished Investigator Award (2014). He is past president of the American College of Nuclear Medicine and Society of Nuclear Medicine and Molecular Imaging, chairs the U.S. Nuclear Regulatory Commission Advisory Committee on Medical Uses of Isotopes (2024-2027), serves as a Director of the American Board of Nuclear Medicine, and holds associate editor positions at the Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, and others.